Unknown

Dataset Information

Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.


ABSTRACT:

Background

Low-molecular-weight heparins (LMWHs) and heparinoids are anticoagulants that may have more powerful antithrombotic effects than standard unfractionated heparin (UFH) but a lower risk of bleeding complications. This is an update of the original Cochrane Review of these agents, first published in 2001 and last updated in 2008.

Objectives

To determine whether antithrombotic therapy with LMWHs or heparinoids is associated with a reduction in the proportion of people who are dead or dependent for activities in daily living compared with UFH.

Search methods

We searched the Cochrane Stroke Group Trials Register (last searched February 2017), the Cochrane Central Register of Controlled Trials (CENTRAL: the Cochrane Library Issue 1, 2017), MEDLINE (1966 to February

SUBMITTER: Sandercock PA 

PROVIDER: S-EPMC6478133 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature